Human MDA-MB-468 / Luciferase & RFP Stable Cells


human MDA-MB-468 cell line co-express Luciferase and GFP dual report, containing puromycin selection.


Human MDA-MB-468 Cell line is derived from the pleural effusion of a 51-year-old black woman in 1977, with metastatic adenocarcinoma of the breast. It has proven useful for the study of metastasis, migration, and breast cancer proliferation, and used to test chemical breast cancer treatments

This Luciferase & RFP / human MDA-MB-468 cell line was transformed via Lentivirus transduction. It has the Luciferase and RFP was constitutively co-expressed under EF1a promoter, as two separate proteins (not as fusion), mediated via 2A element. The Puromycin resistance marker was expressed under Rsv promoter. The following express cassette was integrated into cell-line’s genome. 

Lentivector scheme express Luc and RFP

Each cell demonstrates a strong RFP fluorescent signal (see sample image below). Its chem-luminescence signal was verified via luciferase assay using the D-luciferin substrate. And its signal can be detected, in vitro and in vivo.

RFP and Luciferase co-expression under EF1a promoter

Sold at:  1 vial x (2 x 106 cells)/vial, see details in Product Manual.

Cat# SC092-LR